Abstract
Purpose
To study the relation between retinal and tunica vasculosa lentis (TVL) disease in ROP. Although the clinical hallmark of retinopathy of prematurity (ROP) is abnormal retinal blood vessels, the vessels of the anterior segment, including the TVL, are also altered.
Methods
ROP was induced in Long Evans pigmented and Sprague-Dawley albino rats; room-air-reared (RAR) rats served as controls. Then, fluorescein angiographic images of the TVL and retinal vessels were serially obtained with a scanning laser ophthalmoscope (SLO) near the height of retinal vascular disease, ∼20 days-of-age, and again at 30 and 64 days-of-age. Additionally, electroretinograms (ERGs) were obtained prior to the first imaging session. The TVL images were analyzed for percent coverage of the posterior lens. The tortuosity of the retinal arterioles was determined using Retinal Image multiScale Analysis (RISA; Gelman et al., 2005).
Results
In the youngest ROP rats, the TVL was dense, while in RAR rats, it was relatively sparse. By 30 days, the TVL in RAR rats had almost fully regressed, while in ROP rats it was still pronounced. By the final test age, the TVL had completely regressed in both ROP and RAR rats. In parallel, the tortuous retinal arterioles in ROP rats resolved with increasing age. ERG components indicating postreceptoral dysfunction, the b-wave and oscillatory potentials (OPs), were attenuated in ROP rats.
Conclusions
These findings underscore the retinal vascular abnormalities and, for the first time, show abnormal anterior segment vasculature in the rat model of ROP. There is delayed regression of the TVL in the rat model of ROP. This demonstrates that ROP is a disease of the whole eye.
Introduction
The clinical hallmark of retinopathy of prematurity (ROP) is abnormal retinal blood vessels but, in fact, ROP is a disease of the whole eye. For instance, infants born prematurely, especially those with ROP, are at increased risk for developing a range of structural ophthalmic sequelae including impaired ocular growth and increased incidence and magnitude of refractive error, particularly myopia [1, 2]. Myopia is a mismatch between the light-focusing power of the anterior segment and the axial length of the eye in which the visual image comes to a focus in front of the retina. Myopia is, therefore, typically associated with longer-than-average eyes [3]. Paradoxically, in ROP myopia the eye is often short [1, 2, 4, 5]; the refractive power of the lens and cornea must be higher than normal. In addition, visual impairment, with a basis in the neural retina, is commonly found in subjects with a history of ROP, even when the vasculopathy was mild [6, 7], and an increasingly large body of evidence indicates that the appearance of the abnormal retinal blood vessels in ROP is actually instigated by changes in the neural retina [8, 9]. Thus, these common ROP outcomes – vascular, structural, and neural – are likely interrelated.
In common with the vessels of the posterior eye, the vessels of the anterior segment are abnormal in ROP. The severity of these abnormalities is associated with the severity of the retinal disease [10]. Persistent and dilated iridic vessels are known to be prognostic of progression to severe ROP as defined by the retinal vessels [10]. The tunica vasculosa lentis (TVL), the part of the hyaloid that supplies the developing lens, normally regresses by term but is present preterm [11, 12] and persists, much engorged, in severe ROP [12, 13]. Changes to the TVL may affect development of the anterior segment and contribute to the broad distribution of refractive errors in ROP that is well-documented [14, 15].
Rat pups exposed to alternating relatively high and relatively low oxygen during the first weeks after birth develop a retinopathy that models human ROP [16, 17]. This oxygen-induced retinopathy represents a convenient in vivo model in which to study ROP that has been widely adopted, the so-called “ROP rat.” The ROP rat's vascular abnormalities include an avascular peripheral retina and neovascularization [18-20], as in human ROP [21]. The original ROP rat was the albino Sprague-Dawley. However, recent studies suggest that retinopathy in the pigmented rat may be just as, if not more, severe [22, 23]. Also as in human ROP, retinal function is persistently abnormal [24-33]. Furthermore, while the regression of the rat hyaloid is normally well coordinated with the development of other ocular structures, such as the vitreous chamber and crystalline lens, in the ROP rat, growth of ocular structures and hyaloidal regression proceed in a relatively uncontrolled manner [34]. Image analysis was used to investigate the development of the retinal and TVL vessels and the electroretinogram (ERG) to study retinal function in the ROP rat, albino and pigmented. The inclusion of pigmented animals provided increased fluorescein contrast against the background choroidal vasculature. The hypothesis that retinal vascular and neural disease would be associated with increased hyperemia of the TVL was tested.
Methods
Subjects
Seven Long Evans pigmented and six Sprague-Dawley albino rats were studied. All animals were born in Boston Children's Hospital. There, three Long Evans and three Sprague-Dawley rats had retinopathy induced following the Penn et al. “50/10” paradigm [18] as previously described [25, 27, 31, 35]. In brief, to induce retinopathy, newborn rat pups were exposed to alternating 24 hour periods of 50% and 10% oxygen starting on the day of birth and lasting for two weeks, when they were returned to room air (∼21% oxygen). Littermates were room-air-reared (RAR) and served as controls. The rats, along with their nursing dam, were shipped overnight for study at the Centre for Ophthalmology at the University of Tübingen, Germany. There, ERGs were obtained and the animals were imaged at 19-22 days-of-age (∼20), 30 days-of-age, and 64 days-of-age, as described below. During the course of the study, one Long Evans ROP rat was lost after the first examination, and one Long Evans RAR was lost after the examination at 30 days. The institutional animal care and use committees at each respective institution approved these experiments.
Electroretinography
In the ∼20-day-old rats, immediately prior to imaging, ERGs were recorded binocularly as described previously [36]. Rats were dark-adapted overnight and anesthetized (at 64 days-of-age, 87.5 mg/kg ketamine and 12.5 mg/kg xylazine; at younger ages, 46.8 mg/kg ketamine and 9.3 mg/kg xylazine). Gold-wire ring electrodes were placed on the corneae, and silver needle electrodes served as reference (forehead) and ground (tail). The ERG apparatus consisted of a Ganzfeld bowl, a DC amplifier, and a PC-based control and recording unit (Multiliner Vision; VIASYS Healthcare GmbH, Hoechberg, Germany). The pupils were dilated with tropicamide eye drops (0.5%; Mydriaticum Stulln, Pharma Stulln, Stulln, Germany). Flash ERGs were elicited from the dark-adapted eyes using stimuli ranging from 10−4 to 25 cd·s·m-2, in ten increasingly bright steps. Ten responses were averaged at each stimulus level. Band-pass filter cut-off frequencies were 0.3 and 300 Hz.
The activation of phototransduction was characterized by fit of the Hood and Birch [37] formulation of the Lamb and Pugh [38, 39] model to responses at the two highest intensity levels. The key parameter extracted from this model, RmP3 (μV), describes the saturated amplitude of the rod photoreceptor response. Postreceptor cell function, RmP2 (μV), was calculated from the saturating bipolar cell response [40]. Inner retinal responses (e.g., amacrine and ganglion cells) were evaluated from the saturating energy in the oscillatory potentials (OPs), Em (μV2·s-1) [29]; the square root of OP energy (Em½) was used in the final analysis as it is proportional to summed OP amplitude ( ∝μV). All response parameters were respectively derived from both eyes and then averaged to produce a single value for each animal.
In vivo imaging
Scanning-laser ophthalmoscopy (SLO) images were obtained from anesthetized rats (immediately after ERG recordings, at ∼20 days), as described previously, using a Heidelberg Retina Angiograph (HRA I; Heidelberg Engineering, Heidelberg, Germany) [45]. The HRA I features two visible argon wavelengths (488 nm/514 nm) and two infrared diode lasers (795 nm/830 nm). To image the retinal vessels and TVL, we performed fluorescein angiography (FLA) at three time points using the 488 nm laser stimulus with a barrier filter at 500 nm. Fluorescein-Na solution (University Pharmacy; University of Tübingen, Germany) was injected subcutaneously for rats smaller than 120 g and intravenously for rats larger than 120 g. Fluorescein-Na dosing was 12.5 mg for rats weighing less than 50 g, 25-50 mg for rats weighing 50-120 g, or 2.5 mg for rats weighing more than 120 g. The images were obtained with the confocal plane in two respective positions: at the retinal surface to capture an ∼20° field of the ocular fundus (centered on the optic disk), or at the back of the lens to capture the TVL.
Tortuosity of the retinal arterioles (TA) was evaluated in the FLA angiograms using Retinal Image multiScale Analysis (RISA) software as previously described [27, 31, 41]. Briefly, each vessel was cropped from the main image and segmented individually. RISA constructed a skeleton and marked terminal and bifurcation points. The operator then selected the vessel segments for analysis and RISA automatically calculated the integrated curvature for the selected segments of each vessel. Arteriolar tortuosity, TA (radians·pixel-1), was calculated for each subject as the mean integrated curvature of all arterioles in each eye (median 6). TVL coverage was measured using the ‘Trainable Segmentation’ plugin [42] in Fiji [43]. The operator identified a few regions of the image as corresponding to background and vessels, and the computer automatically segmented all pixels containing vasculature. The operator then bounded the lens to circumscribe a region of interest (ROI) and Fiji computed the ratio of vascular to total pixels (so that 0% would be a completely avascular lens and 100% would be a lens completely covered by TVL). A sample segmentation is shown in Figure 1.
Figure 1.
Sample evaluation of the tunica vasculosa lentis (TVL) coverage of the lens. A) Fluorescence angiographic image of the TVL in a 22-day-old Long Evans ROP rat obtained by scanning laser ophthalmoscopy (SLO). B) The regions of the SLO image identified as vessels by the ‘Trainable Segmentation’ plugin [42] in Fiji [43] are highlighted (red) and the region of interest (ROI) is indicated (yellow dashes). C) The cropped region of interest is segmented into vasculature (red pixels) and background (white pixels). The ratio of red-to-white pixels was used to calculate percent TVL coverage of the lens.
Analyses
All RISA, TVL, and ERG parameters were expressed as log values, and individual values were then normalized to the mean value in the RAR rats (Δ Log RAR). Statistical tests are described in the relevant section of the Results.
Results
In the ROP eyes, as shown in a representative set of images from a Long Evans rat (Figure 2), the tortuosity of the retinal arterioles was higher at young ages and decreased with age. Simultaneously, the TVL regressed between 22 and 30 days-of-age and was no longer detectable by 64 days-of-age. Figure 3 displays the retinal vessels and TVL in an age-matched RAR eye. TA was lower in RAR rats than in ROP rats and did not change much throughout the developmental period studied. As in ROP, TVL coverage regressed between 22 and 30 days-of-age to become undetectable by 64 days-of-age, but coverage was much less in RAR than ROP rats. Indeed, in the Long Evans rats in particular, TVL coverage in ROP eyes was so great that it was an average of 0.5 log units higher at age 30 days (Figure 2) than in RAR eyes at age 22 days (Figure 3), despite the eight additional days for regression to occur in the ROP rat.
Figure 2.
Scanning laser ophthalmoscope (SLO) fluorescein angiographs of the retinal surface (top) and the back of the lens (bottom) in a ROP Long Evans rat at the postnatal days (P) indicated. The proportion of adult normal tortuosity of each retinal arteriole is displayed (red boxes) and the average tortuosity for all arterioles at each age, TA, is displayed below the respective image. TA decreased steadily from P22 to P64. The proportion of the TVL covering the lens is shown for the first two ages. TVL imaging was unsuccessful in adult rats.
Figure 3.
2. Scanning laser ophthalmoscope (SLO) fluorescein angiographs of the retinal surface (top) and the back of the lens (bottom) in a RAR Long Evans rat at the postnatal days (P) indicated. The proportion of adult normal tortuosity of each retinal arteriole is displayed (blue boxes) and the average tortuosity for all arterioles at each age, TA, is displayed below the respective image. TA was very stable throughout development, and much lower than in age matched ROP rats (Figure 2). The proportion of the TVL covering the lens is shown for the first two ages. By P30, the TVL nearly completely regressed; note that while the retinal surface vessels are visible in the background of the P30 lens image, there is only a wisp of lens vasculature in the foreground.
ERGs were also clearly altered in ROP eyes. Figure 4 shows mean±SD ERGs obtained at 0.0010, 1.0, and 25 cd·s·m-2 from the ROP and RAR Long Evans rats. Particularly, postreceptoral components such as the b-wave and oscillatory potentials were found to be reduced in ROP eyes, whereas direct photoreceptor contributions (such as the a-wave in saturation) appeared not to be substantially affected.
Figure 4.
Averaged responses (lines) and one SD (fills) from the 22-day-old Long Evans ROP (red) and the RAR (blue) rats for three stimuli selected from the dark-adapted ERG intensity series. The dim flash (bottom) evoked a marked b-wave in the RAR rats, but – in the absence of a discernible a-wave – almost no response in the ROP rats. The moderate flash (middle) evoked a pronounced a-wave in both the ROP and RAR rats, but elicited a much-attenuated postreceptor response (b-wave and OPs) in the ROP rats. The bright flash (top) evoked a saturating a-wave in both groups. In the RAR rats, the a-wave was large, the OPs were pronounced and the b-wave rose well above baseline; in the ROP rats, both the b-wave and the OPs were strikingly enervated but the a-wave was relatively preserved.
Figure 5 plots key vascular and ERG parameters (in Δ Log RAR units) obtained in ∼20-day-old ROP and RAR, Long Evans and Sprague-Dawley rats. Group (ROP vs. RAR) by strain (Long Evans vs. Sprague-Dawley) ANOVA on TA (panel A) indicated that the increase in tortuosity in ROP was significant (Fgroup=12.5; df=1,9; p=0.0063). TVL coverage (panel B) likewise was significantly greater in ROP rats than RAR rats (Fgroup=66.4; df=1,9; p=1.9×10-5). A group by strain by parameter (RmP3, RmP2, Em½; Panels C-E) repeated measures ANOVA detected that ROP rats had reduced retinal function (Fgroup=69.6; df=1,9; p=1.6×10-5); notably, the amplitudes of inner retinal (postrecpetor) responses (RmP2, Em½) were increasingly more affected by ROP than photoreceptor responses (Fgroup×parameter=130; df=,18; p=2.0×10-11). In panel F, mean±SEM values for rod photoreceptor (RmP3), bipolar cell, (RmP2) and inner retinal (Em½) response amplitudes are plotted.
Figure 5.
Log individual (symbols) and mean (line) parameter values in RAR (blue) and ROP (red) Sprague-Dawley (open circles) and Long Evans (filled triangles) rats plotted as the proportion normal (mean of all RAR rats) are shown in panels A-E for tortuosity of the arterioles (panel A), TVL coverage of the lens (panel B), amplitude of the saturated rod photoreceptor response (panel C), amplitude of the saturated bipolar cell response (panel D), and amplitude (square root of energy) in the saturated oscillatory potentials (OPs; panel E). In panel F, response parameters from both strains in photoreceptor (RmP3), bipolar (RmP2) and inner retinal cells (Em½) show that higher order responses are more attenuated in ROP than RAR rats.
From the data obtained in the ∼20 day-old ROP rats, the parameters TA, RmP3, RmP2, and Em½ were plotted as a function of TVL coverage and inspected for significant monotonic relationships using Spearman's rank correlation (ρ) statistical test. TA and TVL coverage showed a perfect, positive rank correlation (ρ=1) with a nearly linear log TA vs. log TVL product moment correlation (r2=0.90, slope=0.42). Em½ was also significantly associated with TVL (ρ=-0.87; p=0.019). These results are consistent with anterior blood vessels, retinal blood vessels, and neural retinal function being mutually affected by ROP.
Discussion
Despite the fact that ROP is clinically characterized by abnormalities in the retinal vasculature, dilated and engorged hyaloidal and iridic vasculature are also conspicuous in ROP. The ROP rat is well documented to display increased retinal vascular tortuosity, and herein we show that this occurs in parallel with an exuberant vascularization of the TVL.
The tortuosity of the retinal arterioles resolved from ∼20 days-of-age (near the height of the vascular abnormalities) to adulthood, during which time the TVL completely regressed. In cross-sectional data, a one-to-one correlation between retinal vessel tortuosity and TVL lens coverage in ROP rats evidenced a linkage between these parameters. With respect to the increased tortuosity of the retinal arterioles: It may be a direct consequence of the reduced size of the vascular bed; like the meanders of a river, tortuosity may be an attempt to reduce flow velocity, and thus increase perfusion. With respect to the TVL: Reduced perfusion causes the retina to release a variety of compensatory factors, such as VEGF. Perhaps, increased levels of such vasoactive factors lead, in turn, to persistence of vitreous vasculature, including profuse TVL. Consistent with earlier studies showing greater abnormality in pigmented than albino ROP rats [22, 23], both retinal vessel tortuosity and TVL lens coverage were greater in the Long Evans than Sprague-Dawley rats. Furthermore, the strong association with inner retinal function (Em½) suggests that these same mechanisms may also pattern neural development. The retinal vasculature and the postreceptor neural retina are in close physical proximity, are immature at the same ages, and develop together. Indeed, we have identified interrelations between postreceptor retinal sensitivity, retinal vascular abnormality (TA), and mRNA expression of the growth factors VEGF164 and Sema3A [31], which are known to cooperatively control both angiogenesis and neurogenesis [44, 45].
In our studies of human ROP patients, we are confronted repeatedly with these issues: Even when the vascular disease is mild and resolves without intervention, ROP eyes are at greatly heightened risk for persistent visual dysfunction that is attributable to the retina, arrested eye growth, and high refractive error, especially myopia. In the ROP eye, it is plausible that anterior segment development would be profoundly altered by this anomalous, persistent vascularization. For instance, the thicker lens that has been documented in the biometry of ROP eyes [46, 47] may be one consequence. The paradoxical myopia, attributed in part to the thicker lens, might therefore be secondary, in part, to the altered TVL. Since the ROP rat's lens contributes approximately two thirds of the refracting power of its eye [48], it is an attractive system in which to study the role of the lens in ROP myopia.
Acknowledgments
This work was supported by the Massachusetts Lions Eye Research Fund (RMH), the Deutsche Forschungsgemeinschaft Se837/5-2 and 6-2 (MWS), NIH EY020308 (JDA), and the Charles H. Hood Foundation (JDA).
References
- 1.Fledelius HC. Pre-term delivery and the growth of the eye. An oculometric study of eye size around term-time. Acta Ophthalmol. 1992;(Suppl):10–15. doi: 10.1111/j.1755-3768.1992.tb04915.x. [DOI] [PubMed] [Google Scholar]
- 2.Fledelius HC. Pre-term delivery and subsequent ocular development. A 7-10 year follow-up of children screened 1982-84 for ROP. 4) Oculometric - and other metric considerations. Acta Ophthalmol Scand. 1996;74:301–305. doi: 10.1111/j.1600-0420.1996.tb00097.x. [DOI] [PubMed] [Google Scholar]
- 3.Morgan IG. The biological basis of myopic refractive error. Clin Exp Optom. 2003;86:276–288. doi: 10.1111/j.1444-0938.2003.tb03123.x. [DOI] [PubMed] [Google Scholar]
- 4.O'Connor AR, Stephenson T, Johnson A, Tobin MJ, Moseley MJ, Ratib S, Ng Y, Fielder AR. Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity. Pediatrics. 2002;109:12–18. doi: 10.1542/peds.109.1.12. [DOI] [PubMed] [Google Scholar]
- 5.Cook A, White S, Batterbury M, Clark D. Ocular growth and refractive error development in premature infants without retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2003;44:953–960. doi: 10.1167/iovs.02-0124. [DOI] [PubMed] [Google Scholar]
- 6.Dobson V, Quinn GE, Summers CG, Saunders RA, Phelps DL, Tung B, Palmer EA. Effect of acute-phase retinopathy of prematurity on grating acuity development in the very low birth weight infant. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Investigative ophthalmology & visual science. 1994;35:4236–4244. [PubMed] [Google Scholar]
- 7.O'Connor AR, Stephenson TJ, Johnson A, Tobin MJ, Ratib S, Moseley M, Fielder AR. Visual function in low birthweight children. The British journal of ophthalmology. 2004;88:1149–1153. doi: 10.1136/bjo.2003.035154. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fulton AB, Akula JD, Mocko JA, Hansen RM, Benador IY, Beck SC, Fahl E, Seeliger MW, Moskowitz A, Harris ME. Retinal degenerative and hypoxic ischemic disease. Doc Ophthalmol. 2009;118:55–61. doi: 10.1007/s10633-008-9127-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Joyal JS, Sitaras N, Binet F, Rivera JC, Stahl A, Zaniolo K, Shao Z, Polosa A, Zhu T, Hamel D, Djavari M, Kunik D, Honore JC, Picard E, Zabeida A, Varma DR, Hickson G, Mancini J, Klagsbrun M, Costantino S, Beausejour C, Lachapelle P, Smith LE, Chemtob S, Sapieha P. Ischemic neurons prevent vascular regeneration of neural tissue by secreting semaphorin 3A. Blood. 2011;117:6024–6035. doi: 10.1182/blood-2010-10-311589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Kivlin JD, Biglan AW, Gordon RA, Dobson V, Hardy RA, Palmer EA, Tung B, Gilbert W, Spencer R, Cheng KP, Buckley E. Early retinal vessel development and iris vessel dilatation as factors in retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) Cooperative Group. Arch Ophthalmol. 1996;114:150–154. doi: 10.1001/archopht.1996.01100130144005. [DOI] [PubMed] [Google Scholar]
- 11.Terry TL. Fibroblastic Overgrowth of Persistent Tunica Vasculosa Lentis in Infants Born Prematurely: II. Report of Cases-Clinical Aspects. Trans Am Ophthalmol Soc. 1942;40:262–284. [PMC free article] [PubMed] [Google Scholar]
- 12.Soh Y, Fujino T, Hatsukawa Y. Progression and timing of treatment of zone I retinopathy of prematurity. Am J Ophthalmol. 2008;146:369–374. doi: 10.1016/j.ajo.2008.05.010. [DOI] [PubMed] [Google Scholar]
- 13.Lorenz B, Spasovska K, Elflein H, Schneider N. Wide-field digital imaging based telemedicine for screening for acute retinopathy of prematurity (ROP). Six-year results of a multicentre field study. Graefes Arch Clin Exp Ophthalmol. 2009;247:1251–1262. doi: 10.1007/s00417-009-1077-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Quinn GE, Dobson V, Kivlin J, Kaufman LM, Repka MX, Reynolds JD, Gordon RA, Hardy RJ, Tung B, Stone RA. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group Ophthalmology. 1998;105:1292–1300. doi: 10.1016/s0161-6420(98)97036-1. [DOI] [PubMed] [Google Scholar]
- 15.Quinn GE, Dobson V, Repka MX, Reynolds J, Kivlin J, Davis B, Buckley E, Flynn JT, Palmer EA. Development of myopia in infants with birth weights less than 1251 grams. The Cryotherapy for Retinopathy of Prematurity Cooperative Group Ophthalmology. 1992;99:329–340. doi: 10.1016/s0161-6420(92)31968-2. [DOI] [PubMed] [Google Scholar]
- 16.Cunningham S, Fleck BW, Elton RA, McIntosh N. Transcutaneous oxygen levels in retinopathy of prematurity. Lancet. 1995;346:1464–1465. doi: 10.1016/s0140-6736(95)92475-2. [DOI] [PubMed] [Google Scholar]
- 17.Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34:576–585. [PubMed] [Google Scholar]
- 18.Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res. 1994;36:724–731. doi: 10.1203/00006450-199412000-00007. [DOI] [PubMed] [Google Scholar]
- 19.Penn JS, Henry MM, Wall PT, Tolman BL. The range of PaO2variation determines the severity of oxygen-induced retinopathy in newborn rats. Invest Ophthalmol Vis Sci. 1995;36:2063–2070. [PubMed] [Google Scholar]
- 20.Barnett JM, Yanni SE, Penn JS. The development of the rat model of retinopathy of prematurity. Documenta ophthalmologica. Advances in ophthalmology. 2010;120:3–12. doi: 10.1007/s10633-009-9180-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lepore D, Molle F, Pagliara MM, Baldascino A, Angora C, Sammartino M, Quinn GE. Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity. Ophthalmology. 2011;118:168–175. doi: 10.1016/j.ophtha.2010.04.021. [DOI] [PubMed] [Google Scholar]
- 22.Dorfman AL, Polosa A, Joly S, Chemtob S, Lachapelle P. Functional and structural changes resulting from strain differences in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2009;50:2436–2450. doi: 10.1167/iovs.08-2297. [DOI] [PubMed] [Google Scholar]
- 23.van Wijngaarden P, Coster DJ, Brereton HM, Gibbins IL, Williams KA. Strain-dependent differences in oxygen-induced retinopathy in the inbred rat. Invest Ophthalmol Vis Sci. 2005;46:1445–1452. doi: 10.1167/iovs.04-0708. [DOI] [PubMed] [Google Scholar]
- 24.Dembinska O, Rojas LM, Chemtob S, Lachapelle P. Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002;43:2481–2490. [PubMed] [Google Scholar]
- 25.Liu K, Akula JD, Falk C, Hansen RM, Fulton AB. The retinal vasculature and function of the neural retina in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006;47:2639–2647. doi: 10.1167/iovs.06-0016. [DOI] [PubMed] [Google Scholar]
- 26.Liu K, Akula JD, Hansen RM, Moskowitz A, Kleinman MS, Fulton AB. Development of the electroretinographic oscillatory potentials in normal and ROP rats. Invest Ophthalmol Vis Sci. 2006;47:5447–5452. doi: 10.1167/iovs.06-0702. [DOI] [PubMed] [Google Scholar]
- 27.Akula JD, Hansen RM, Martinez-Perez ME, Fulton AB. Rod photoreceptor function predicts blood vessel abnormality in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4351–4359. doi: 10.1167/iovs.07-0204. [DOI] [PubMed] [Google Scholar]
- 28.Berkowitz BA, Roberts R, Penn JS, Gradianu M. High-resolution manganese-enhanced MRI of experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:4733–4740. doi: 10.1167/iovs.06-1516. [DOI] [PubMed] [Google Scholar]
- 29.Akula JD, Mocko JA, Moskowitz A, Hansen RM, Fulton AB. The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2007;48:5788–5797. doi: 10.1167/iovs.07-0881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Dorfman A, Dembinska O, Chemtob S, Lachapelle P. Early manifestations of postnatal hyperoxia on the retinal structure and function of the neonatal rat. Invest Ophthalmol Vis Sci. 2008;49:458–466. doi: 10.1167/iovs.07-0916. [DOI] [PubMed] [Google Scholar]
- 31.Akula JD, Mocko JA, Benador IY, Hansen RM, Favazza TL, Vyhovsky TC, Fulton AB. The neurovascular relation in oxygen-induced retinopathy. Mol Vis. 2008;14:2499–2508. [PMC free article] [PubMed] [Google Scholar]
- 32.Berkowitz BA, Roberts R. Evidence for a critical role of panretinal pathophysiology in experimental ROP. Documenta ophthalmologica. Advances in ophthalmology. 2010;120:13–24. doi: 10.1007/s10633-009-9175-8. [DOI] [PubMed] [Google Scholar]
- 33.Berkowitz BA, Bissig D, Bergman D, Bercea E, Kasturi VK, Roberts R. Intraretinal calcium channels and retinal morbidity in experimental retinopathy of prematurity. Molecular vision. 2011;17:2516–2526. [PMC free article] [PubMed] [Google Scholar]
- 34.Berkowitz BA, Lukaszew RA, Mullins CM, Penn JS. Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci. 1998;39:391–396. [PubMed] [Google Scholar]
- 35.Akula JD, Hansen RM, Tzekov R, Favazza TL, Vyhovsky TC, Benador IY, Mocko JA, McGee D, Kubota R, Fulton AB. Visual cycle modulation in neurovascular retinopathy. Exp Eye Res. 2010;91:153–161. doi: 10.1016/j.exer.2010.04.008. [DOI] [PubMed] [Google Scholar]
- 36.Seeliger MW, Grimm C, Stahlberg F, Friedburg C, Jaissle G, Zrenner E, Guo H, Reme CE, Humphries P, Hofmann F, Biel M, Fariss RN, Redmond TM, Wenzel A. New views on RPE65 deficiency: the rod system is the source of vision in a mouse model of Leber congenital amaurosis. Nat Genet. 2001;29:70–74. doi: 10.1038/ng712. [DOI] [PubMed] [Google Scholar]
- 37.Hood DC, Birch DG. Rod phototransduction in retinitis pigmentosa: estimation and interpretation of parameters derived from the rod a-wave. Invest Ophthalmol Vis Sci. 1994;35:2948–2961. [PubMed] [Google Scholar]
- 38.Lamb TD, Pugh EN., Jr A quantitative account of the activation steps involved in phototransduction in amphibian photoreceptors. J Physiol. 1992;449:719–758. doi: 10.1113/jphysiol.1992.sp019111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Pugh EN, Jr, Lamb TD. Amplification and kinetics of the activation steps in phototransduction. Biochim Biophys Acta. 1993;1141:111–149. doi: 10.1016/0005-2728(93)90038-h. [DOI] [PubMed] [Google Scholar]
- 40.Robson JG, Frishman LJ. Dissecting the dark-adapted electroretinogram. Doc Ophthalmol. 1998;95:187–215. doi: 10.1023/a:1001891904176. [DOI] [PubMed] [Google Scholar]
- 41.Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005;46:4734–4738. doi: 10.1167/iovs.05-0646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Kaynig V, Arganda-Carreras I, Cardona A, Trainable Segmentation Plugin, Kaynig, V and Arganda-Carreras, I, Editors. 2010, Fiji.
- 43.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bates D, Taylor GI, Minichiello J, Farlie P, Cichowitz A, Watson N, Klagsbrun M, Mamluk R, Newgreen DF. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin-1. Dev Biol. 2003;255:77–98. doi: 10.1016/s0012-1606(02)00045-3. [DOI] [PubMed] [Google Scholar]
- 45.Bagnard D, Vaillant C, Khuth ST, Dufay N, Lohrum M, Puschel AW, Belin MF, Bolz J, Thomasset N. Semaphorin 3A-vascular endothelial growth factor-165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci. 2001;21:3332–3341. doi: 10.1523/JNEUROSCI.21-10-03332.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Cook A, White S, Batterbury M, Clark D. Ocular growth and refractive error development in premature infants with or without retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2008;49:5199–5207. doi: 10.1167/iovs.06-0114. [DOI] [PubMed] [Google Scholar]
- 47.Chen TC, Tsai TH, Shih YF, Yeh PT, Yang CH, Hu FC, Lin LL, Yang CM. Long-term evaluation of refractive status and optical components in eyes of children born prematurely. Invest Ophthalmol Vis Sci. 2010;51:6140–6148. doi: 10.1167/iovs.10-5234. [DOI] [PubMed] [Google Scholar]
- 48.Chui TY, Bissig D, Berkowitz BA, Akula JD. Refractive Development in the “ROP Rat”. J Ophthalmol. 2012;2012;956705 doi: 10.1155/2012/956705. [DOI] [PMC free article] [PubMed] [Google Scholar]





